Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Aaronson

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cancer Research|April 5, 2005
Evidence against a role for SV40 in human mesotheliomaJames J Manfredi, Jianli Dong, Wen-jun Liu, et al.
Molecular Cell|July 26, 2016
CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver MutationsAlexis Guernet, Sathish Kumar Mungamuri, Dorthe Cartier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Blood Advances|January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCsGeorgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
The EMBO Journal|February 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4Yitian Xu, Kyeongah Kang, Brian A Coakley, et al.
Molecular Cancer Research : MCR|June 22, 2019
Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory CascadeYixuan Gong, Li Wang, Haocheng Yu, et al.
Bioconjugate Chemistry|March 21, 2017
Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal ImagingFrancois Fay, Line Hansen, Stefanie J C G Hectors, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer Research|April 5, 2005
Evidence against a role for SV40 in human mesotheliomaJames J Manfredi, Jianli Dong, Wen-jun Liu, et al.
Molecular Cell|July 26, 2016
CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver MutationsAlexis Guernet, Sathish Kumar Mungamuri, Dorthe Cartier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
Cancer Discovery|February 11, 2021
Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF SignalingChristos Adamopoulos, Tamer A Ahmed, Maxwell R Tucker, et al.
Blood Advances|January 18, 2022
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCsGeorgios Asimomitis, André G Deslauriers, Andriana G Kotini, et al.
Nature Cancer|September 27, 2021
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degradersXuewei Wu, Xiaobao Yang, Yan Xiong, et al.
The EMBO Journal|February 13, 2025
Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4Yitian Xu, Kyeongah Kang, Brian A Coakley, et al.
Molecular Cancer Research : MCR|June 22, 2019
Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory CascadeYixuan Gong, Li Wang, Haocheng Yu, et al.
Bioconjugate Chemistry|March 21, 2017
Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal ImagingFrancois Fay, Line Hansen, Stefanie J C G Hectors, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Pageof 9